Pediatric ALL patients showed enhanced levels of ST3GAL5 (GM3 synthase), which catalyzes α2-3-sialylation of lactosylceramide (LacCer), and resulting ganglioside GM3 (101). The gene discussed is ST3GAL5; the disease is acute lymphoblastic leukemia.